Our primary hypothesis is that bioactive vitamin D (1,25-(OH)2-D3 [calcitriol]), added to inhibition of the RAAS, via ACE inhibition or ARB, has a differential impact on urine albumin excretion in T2DM compared to RAAS inhibition alone. The gene discussed is ACE; the disease is type 2 diabetes mellitus.